1 year return (CAGR)
-89.63%
LENZ Therapeutics Inc Exchange (NASDAQ, USD)
LENZ
4.14
-0.24 (-5.37%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
23.78%
5 year return (CAGR)
-27.02%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
132.91M
Price/Sales
6.19
Ent value
126.03M
Price/Book
0.61
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-19.13%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 4.44 |
| Daily high | 4.44 |
| Daily low | 4.21 |
| Daily Volume | 807K |
| All-time high | 49.05 |
| 1y analyst estimate | 24.00 |
| Beta | 1.63 |
| EPS (TTM) | -4.02 |
| Dividend per share | 0.00 |
| Ex-div date | 22 Mar 2024 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| LENZ | S&P500 | |
| Current price drop from All-time high | -91.56% | -3.06% |
| Highest price drop | -93.98% | -56.47% |
| Date of highest drop | 6 Jan 2023 | 9 Mar 2009 |
| Avg drop from high | -62.37% | -10.68% |
| Avg time to new high | 66 days | 12 days |
| Max time to new high | 844 days | 1805 days |
News
